Toronto, Ontario (PRWEB) September 22, 2011 -- Dalton Pharma Services, a privately owned Canadian pharmaceutical services provider to leading companies, today announced the Company is scheduled to present at the 10th Annual Contract Pharma, Contracting & Outsourcing Conference and Tabletop Exhibition in New Brunswick, New Jersey.
The two day conference and one day exhibition is devoted to outsourcing in pharma and biotech industries. Dalton Pharma Services will be one of 160 exhibitors on September 22, from 10 am to 4 pm. Peter Pekos, Dalton’s President and CEO will be representing the Company and looks forward to discussing your drug development and manufacturing needs with you.
Dalton Chemical Laboratories Inc. o/a Dalton Pharma Services is a Health Canada approved contract pharmaceutical manufacturer that supplies chemistry, analytical and formulation development services to the biotechnology and pharmaceutical industries in the areas of chemistry, medicinal chemistry and fine chemical manufacture. Dalton provides cGMP manufacturing of solid dosage forms and aseptic filling services to its customers at any stage of the regulatory process (Phase I, II, III or commercial). In its state of the art cGMP facilities, Dalton produces active pharmaceutical ingredients at the gram or kilogram scale. Dalton conducts sterile fills to produce batches of finished drug product in vials or syringes, either aseptically filled or terminally sterilized, under fully validated conditions. In addition, Dalton’s analytical chemistry laboratory offers method development, validation and ICH stability programs to its clients. Further information can be found at http://www.dalton.com.